comparemela.com

Latest Breaking News On - Excessive daytime sleepiness - Page 1 : comparemela.com

KP1077 Demonstrates Safety in Idiopathic Hypersomnia Patients

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on.

Delta Wave Sleep Disruption Linked to Increased CV Risk

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.